Versant Venture Management as of Sept. 30, 2017
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Audentes Therapeutics | 38.7 | $51M | 1.8M | 28.15 | |
| Immune Design | 17.7 | $23M | 2.2M | 10.52 | |
| Achaogen | 15.7 | $21M | 1.3M | 16.08 | |
| Ocular Therapeutix (OCUL) | 10.5 | $14M | 2.2M | 6.25 | |
| Clovis Oncology | 6.4 | $8.4M | 102k | 82.32 | |
| Cymabay Therapeutics | 6.3 | $8.3M | 1.0M | 7.88 | |
| Second Sight Med Prods | 4.1 | $5.4M | 4.5M | 1.20 | |
| Opgen | 0.6 | $791k | 2.6M | 0.31 |
